ArticleJournal of clinical microbiology2006
Results of the first World Health Organization international collaborative study of detection of human papillomavirus DNA.
Article in Journal of clinical microbiology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed.
- A human papillomavirus whole genome plasmid repository: A resource for HPV DNA quality control reagents.Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology · 2023Article
- Comparison of Hybribio GenoArray and Roche human papillomavirus (HPV) linear array for HPV genotyping in anal swab samples.Journal of clinical microbiology · 2015Article
- Epidemiology of HPV genotypes in Uganda and the role of the current preventive vaccines: A systematic review.Infectious agents and cancer · 2011Article
- Single-tube multiplex PCR using type-specific E6/E7 primers and capillary electrophoresis genotypes 21 human papillomaviruses in neoplasia.Infectious agents and cancer · 2011Article
- Monitoring of human papillomavirus vaccination.Clinical and experimental immunology · 2011Review
- Human papillomavirus types 52 and 58 are prevalent in uterine cervical squamous lesions from Japanese women.Pathology research international · 2011Article
- Incidence of anogenital warts in Germany: a population-based cohort study.BMC infectious diseases · 2010Article
- Global proficiency study of human papillomavirus genotyping.Journal of clinical microbiology · 2010Article
- RNA (E6 and E7) assays versus DNA (E6 and E7) assays for risk evaluation for women infected with human papillomavirus.Journal of clinical microbiology · 2009Article
- Modified general primer PCR system for sensitive detection of multiple types of oncogenic human papillomavirus.Journal of clinical microbiology · 2009Article
- Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older.International journal of cancer · 2009Article
- Estimation of the incidence of genital warts and the cost of illness in Germany: a cross-sectional study.BMC infectious diseases · 2008Article
- Comparison of linear array and line blot assay for detection of human papillomavirus and diagnosis of cervical precancer and cancer in the atypical squamous cell of undetermined significance and low-grade squamous intraepithelial lesion triage study.Journal of clinical microbiology · 2008Article
- Translational mini-review series on vaccines: Monitoring of human papillomavirus vaccination.Clinical and experimental immunology · 2007Review
- Human papillomavirus quantification in urine and cervical samples by using the Mx4000 and LightCycler general real-time PCR systems.Journal of clinical microbiology · 2007Article
- Prevalence of human papillomavirus genotypes and their variants in high risk West Africa women immigrants in South Italy.Infectious agents and cancer · 2007Article
- An in vitro selection scheme for oligonucleotide probes to discriminate between closely related DNA sequences.Nucleic acids research · 2007Article
- Comparison between the Hybrid Capture II Test and an SPF1/GP6+ PCR-based assay for detection of human papillomavirus DNA in cervical swab samples.Journal of clinical microbiology · 2006Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Twenty-nine laboratories in 12 countries participated in a study to assess the performance of various human papillomavirus (HPV) detection assays through the use of a recombinant HPV DNA standard reagent panel. The panel was designed by a group of HPV experts, and samples were prepared and distributed by the World Health Organization International Laboratory for Standards and Biologicals in The Netherlands. Each panel consisted of 24 coded samples including a dilution series for HPV types 16 and 18, alone or in combination with five other high-risk (HR) HPV types including HPV types 31, 33, 35, 45, and 52, the low-risk HPV type 6, and a negative control. Qualitative assays were generally consistent across laboratories, and most invalid results reflected a lack of HPV test sensitivity. The combined data sets had a proficiency for HPV 16 of 62.5% (15/24) and for HPV 18 of 73.9% (17/23). HPV 31 was the least accurately detected by participating laboratories. Approximately half of participating laboratories failed to detect high concentrations of HPV 31 and, to a lesser extent, to detect HPV types 35, 52, and 6. The panel sample materials offer a source of renewable and reproducible material that could be used in the future development of international standard reagents for calibration of HPV DNA assays and kits.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.